Retreatment with venetoclax and rituximab in CLL patients achieved 100% response rates and prolonged progression-free ...

Dr. Hirsch discusses the promising efficacy and safety of cevertinib for HER2-mutant non-small cell lung cancer, highlighting ...

A Maui Derm 2026 session explored advancements in pediatric dermatology, emphasizing precision medicine and targeted therapies for children.

Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...

Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, yet no 2 cases look alike, says Philip Mease, MD, director of rheumatology and research, Providence Swedish Medical Center, ...

Speakers delved into innovative strategies in skin tumor management, focusing on chemotherapies, patient risk assessment, and evolving treatment protocols.

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

Explore how evolving treatment strategies and biomarkers are transforming the management of HER2-positive breast cancer in clinical practice.

Large language models (LLMs) can provide generally accurate and patient-appropriate information for common postoperative Mohs surgery questions, particularly when guidance is straightforward and ...

It seems there is no text provided for summarization. Please share the content you'd like summarized, and I'll be happy to help!

Jerry Shapiro, MD, discusses strategies for treating patients with scarring and nonscarring alopecia.

The American Academy of Pediatrics (AAP) released its 2026 child and adolescent immunization schedule, which continues to ...